Antidiabetics Market Size, Trends, Growth and Companies 2026-2035
According to Payal Rabde, who specializes in the development , manufacturing, and commercialization of medications, including insulin, GLP-1 receptor agonists, SGLT-2 inhibitors, DPP-4 inhibitors, metformin, sulfonylureas, and other oral antidiabetic drugs, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the antidiabetics market. The global antidiabetics market size was estimated at USD 101.25 billion in 2025 and is predicted to increase from USD 112.18 billion in 2026 to approximately USD 282.1 billion by 2035, expanding at a CAGR of 10.79% from 2026 to 2035.
Last Updated : 13 October 2026
Category: Therapeutic Area
Insight Code: 6705
Format: PDF / PPT / Excel